Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 35.75
+0.91 (2.61%)
Sep 30, 2025, 3:04 PM CST
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 60.45 billion as of October 8, 2025. Its market cap has increased by 93.41% in one year.
Market Cap
60.45B
Enterprise Value
64.29B
Revenue
13.11B
Ranking
n/a
PE Ratio
45.74
Stock Price
35.75
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 60.45B, an increase of 735.05%. That is a compound annual growth rate of 37.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 60.45B | 44.45% |
| Dec 31, 2024 | 41.85B | -11.66% |
| Dec 29, 2023 | 47.37B | -38.44% |
| Dec 30, 2022 | 76.95B | -27.67% |
| Dec 31, 2021 | 106.40B | 12.84% |
| Dec 31, 2020 | 94.29B | 140.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 154.95B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |